Shilpa Medicare Limited, an India-based pharmaceutical company, has sold its wholly owned Canadian subsidiary, Koanna Healthcare Canada Inc., to an individual buyer, Steve N. Slilaty. Under the share sale-purchase agreement executed on January 14, 2026, Koanna Healthcare allotted 28,421,020 equity shares to the buyer for a total consideration of CAD 2,000.
Koanna Healthcare, which operated in Canada as part of Shilpa Medicare’s international footprint, was a non-material subsidiary, contributing only a negligible portion to the company’s overall revenue and net worth. The divestment is not expected to affect Shilpa Medicare’s current financial performance, operational strategy, or raise any related-party transaction concerns.
Shilpa Medicare develops and manufactures specialty and generic pharmaceuticals and maintains operations in international markets through subsidiaries such as Koanna Healthcare. The company continues to focus on expanding its presence in global healthcare markets and delivering a range of pharmaceutical products and services.
The company’s current market capitalization stands at ₹58.19 billion and with an average daily trading volume of 25,779 shares.
